Descrizione Clinica
Vitamins and mineral salts Diathynil 30cpr 5mg Diathynil
DIATHYNIL 5 MG
active ingredients
DIATHYNIL 5 mg tablets Each tablet contains Active ingredient: D(+) biotin mg 5 Excipient with known effects: lactose. Each tablet contains Lactose mg 160 DIATHYNIL 5 mg injectable solution 1 ml vial contains Active ingredient: D(+) biotin mg 5 Excipients with known effects: methyl parahydroxybenzoate (E218), propile parahydroxybenzoate (E217). A vial contains: methyl parahydroxybenzoate (E218) mg 0.8 propile parahydroxybenzoate (E217) mg 0.1 For the full list of excipients, see paragraph 6.1.Excellent
DIATHYNIL 5 mg lactose tablets, corn starch, talc, stearic acid, magnesium stearate. DIATHYNIL 5 mg injectable solution dihydrate monosodium phosphate, monosodium carbonate, methyl parahydroxybenzoate, propile parahydroxybenzoate, water for injectable preparations.Therapeutic indications
Skin affections with seborrheic and desquamative character. In particular: - in adult: seborrheic dermatitis, acne, alopecia of various nature; - in the child: localized dermatitis: diaper dermatitis, redness of skin folds, milk crust. General dermatitis: Leiner-Moussous syndrome. Affections related to vitamin deficiency: gloss with digestive problems.Contraindications
Hypersensitivity to the active ingredient or any of the excipients listed in paragraph 6.1.Population
- Treatment of alopecies and scalp seborrhea Attack treatment: injecting via i.m. or e.v. one or two vials DIATHYNIL, three times a week for six weeks. Maintenance treatment: three tablets DIATHYNIL a day for two months. - Other indications: oral or parental (s.c., i.m., e.v.)| Daily dose | Adult | Child |
| 5 mg tablets | 2-4 | 1-2 |
| Fial 5 mg | 1-4 | 1 |
Conservation
None.Warnings
During therapy, it is recommended to exclude from the diet of the raw egg egg, in which is contained a protein called avidine that is combined with the D(+) biotin inactivating it. DIATHYNIL tablets contains lactose. Patients suffering from rare hereditary problems of galactose intolerance, lactase deficiency, or glucose-galactose mal absorption, should not take this medicine. DIATHYNIL injectable solution contains propile methyl parahydroxybenzoate and parahydroxybenzoate that can cause allergic reactions (also delayed) and, exceptionally, bronchospasm. Interference with clinical laboratory tests Biotin can interfere with laboratory diagnostic tests based on biotin/streptavidine interaction, producing falsely decreased or falsely increased results, depending on the test used. The risk of interference is greater in children and patients with kidney failure and increases when the dose increases. In the interpretation of the results of laboratory tests, biotin interference should be considered, especially if there is a lack of consistency with clinical presentation (e.g., results of thyroid examinations suggesting Graves disease in asymptomatic patients taking biotin or negative false results of troponin examination in patients with myocardial infarction taking biotin). In cases of suspected interference, alternative diagnostic tests are not sensitive to interference with biotin. It is necessary to consult the laboratory staff when preparing laboratory tests in patients taking biotin.Interactions
No notes.Effects
The product is very well tolerated; rare cases of intolerance with erythematous or orthoid skin manifestations have been found. Reporting of suspicious adverse reactions The reporting of suspicious adverse reactions that occur after the authorization of the medicinal product is important, as it allows continuous monitoring of the benefit/risk ratio of the medicinal product. Healthcare workers are required to report any suspected adverse reaction via the national reporting system at the address http://www.agenziafarmaco.gov.it/content/come-segnalare-una-sospetta-reazione-avversaOverdosing
Excluding manifestations of overdose poisoning.The drug can be used during pregnancy and nursing.
Source: Farmadati
